Janus Henderson Group plc 13D and 13G filings for Ligand Pharmaceuticals Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 12:36 pm Purchase | 2024-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | JANUS HENDERSON GROUP PLC JHG | 1,015,023 5.400% | 5,929 (+0.59%) | Filing |
| 2024-11-14 3:19 pm Sale | 2024-09-30 | 13G | Ligand Pharmaceuticals Incorporated LGND | JANUS HENDERSON GROUP PLC JHG | 1,009,094 5.500% | -334,060 (-24.87%) | Filing |
| 2024-02-13 3:39 pm Purchase | 2023-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | JANUS HENDERSON GROUP PLC JHG | 1,343,154 7.700% | 87,881 (+7.00%) | Filing |
| 2023-02-10 3:23 pm Sale | 2022-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | JANUS HENDERSON GROUP PLC JHG | 1,255,273 7.400% | -1,054,786 (-45.66%) | Filing |
| 2022-02-10 4:35 pm Sale | 2021-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | JANUS HENDERSON GROUP PLC JHG | 2,310,059 8.600% | -274,568 (-10.62%) | Filing |
| 2021-02-11 4:42 pm Sale | 2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND | JANUS HENDERSON GROUP PLC JHG | 2,584,628 10.000% | -376,450 (-12.71%) | Filing |